The DOI matches its Crossref record; 426 of the 426 references it cites were found in a registry or an index.
Broad targeting of angiogenesis for cancer prevention and therapy
Open accessAbstract
Deregulation of angiogenesis--the growth of new blood vessels from an existing vasculature--is a main driving force in many severe human diseases including cancer. As such, tumor angiogenesis is important for delivering oxygen and nutrients to growing tumors, and therefore considered an essential pathologic feature of cancer, while also playing a key role in enabling other aspects of tumor pathology such as metabolic deregulation and tumor dissemination/metastasis. Recently, inhibition of tumor angiogenesis has become a clinical anti-cancer strategy in line with chemotherapy, radiotherapy and surgery, which underscore the critical importance of the angiogenic switch during early tumor development. Unfortunately the clinically approved anti-angiogenic drugs in use today are only effective in a subset of the patients, and many who initially respond develop resistance over time. Also, some of the anti-angiogenic drugs are toxic and it would be of great importance to identify alternative compounds, which could overcome these drawbacks and limitations of the currently available therapy. Finding "the most important target" may, however, prove a very challenging approach as the tumor environment is highly diverse, consisting of many different cell types, all of which may contribute to tumor angiogenesis. Furthermore, the tumor cells themselves are genetically unstable, leading to a progressive increase in the number of different angiogenic factors produced as the cancer progresses to advanced stages. As an alternative approach to targeted therapy, options to broadly interfere with angiogenic signals by a mixture of non-toxic natural compound with pleiotropic actions were viewed by this team as an opportunity to develop a complementary anti-angiogenesis treatment option. As a part of the "Halifax Project" within the "Getting to know cancer" framework, we have here, based on a thorough review of the literature, identified 10 important aspects of tumor angiogenesis and the pathological tumor vasculature which would be well suited as targets for anti-angiogenic therapy: (1) endothelial cell migration/tip cell formation, (2) structural abnormalities of tumor vessels, (3) hypoxia, (4) lymphangiogenesis, (5) elevated interstitial fluid pressure, (6) poor perfusion, (7) disrupted circadian rhythms, (8) tumor promoting inflammation, (9) tumor promoting fibroblasts and (10) tumor cell metabolism/acidosis. Following this analysis, we scrutinized the available literature on broadly acting anti-angiogenic natural products, with a focus on finding qualitative information on phytochemicals which could inhibit these targets and came up with 10 prototypical phytochemical compounds: (1) oleanolic acid, (2) tripterine, (3) silibinin, (4) curcumin, (5) epigallocatechin-gallate, (6) kaempferol, (7) melatonin, (8) enterolactone, (9) withaferin A and (10) resveratrol. We suggest that these plant-derived compounds could be combined to constitute a broader acting and more effective inhibitory cocktail at doses that would not be likely to cause excessive toxicity. All the targets and phytochemical approaches were further cross-validated against their effects on other essential tumorigenic pathways (based on the "hallmarks" of cancer) in order to discover possible synergies or potentially harmful interactions, and were found to generally also have positive involvement in/effects on these other aspects of tumor biology. The aim is that this discussion could lead to the selection of combinations of such anti-angiogenic compounds which could be used in potent anti-tumor cocktails, for enhanced therapeutic efficacy, reduced toxicity and circumvention of single-agent anti-angiogenic resistance, as well as for possible use in primary or secondary cancer prevention strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–400 of 426
Phytoestrogens and breast cancer: a complex story
Helferich, W. G., Andrade, J. E., & Hoagland, M. S. (2008) · Inflammopharmacology · doi:10.1007/s10787-008-8020-0 · Cited by 165
Bergman Jungeström, M., Thompson, L. U., & Dabrosin, C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1651 · Cited by 165
Self-citationOhashi, T., Akazawa, T., Aoki, M., Kuze, B., Mizuta, K., Ito, Y., & Inoue, N. (2013) · International Journal of Cancer · doi:10.1002/ijc.28114 · Cited by 164
Heterogeneity of the tumor vasculature: the need for new tumor blood vessel type-specific targets
Nagy, J. A., & Dvorak, H. F. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9500-6 · Cited by 163
Anti-angiogenic activity of triterpene acids
Sohn, K.-H., Lee, H.-Y., Chung, H.-Y., Young, H.-S., Yi, S.-Y., & Kim, K.-W. (1995) · Cancer Letters · doi:10.1016/0304-3835(95)03856-r · Cited by 161
Singh, R. P., Raina, K., Sharma, G., & Agarwal, R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1309 · Cited by 161
Acidic Environment Leads to ROS-Induced MAPK Signaling in Cancer Cells
Riemann, A., Schneider, B., Ihling, A., Nowak, M., Sauvant, C., Thews, O., & Gekle, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022445 · Cited by 160
Jia, C., Wang, T.-T., Liu, W., Fu, B., Hua, X., Wang, G., Li, T.-J., Li, X., Wu, X.-Y., Tai, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063243 · Cited by 156
Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis
Pozzi, A., LeVine, W. F., & Gardner, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205045 · Cited by 154
Tomei, A. A., Siegert, S., Britschgi, M. R., Luther, S. A., & Swartz, M. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900835 · Cited by 154
Kopitz, C., Gerg, M., Bandapalli, O. R., Ister, D., Pennington, C. J., Hauser, S., Flechsig, C., Krell, H., Antolovic, D., Brew, K., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0232 · Cited by 153
Stan, S. D., Zeng, Y., & Singh, S. V. (2008) · Nutrition and Cancer · doi:10.1080/01635580802381477 · Cited by 152
Roenneberg, T. (2013) · Nature · doi:10.1038/498427a · Cited by 150
Huang, W., Tsai, S., Peng, S., Lin, M., Chiang, J., Chiu, Y., Fushiya, S., Tseng, M. T., & Yang, J. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1909 · Cited by 149
Ryder, M. M., Gild, M. L., Hohl, T. M., Pamer, E. G., Knauf, J. A., Ghossein, R. A., Joyce, J. A., & Fagin, J. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054302 · Cited by 149
Penel, N., Adenis, A., & Bocci, G. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.04.009 · Cited by 149
Chronic hypoxia compromises repair of DNA double-strand breaks to drive genetic instability
Kumareswaran, R., Ludkovski, O., Meng, A. X., Sykes, J. R., Pintilie, M., & Bristow, R. G. (2012) · Journal of Cell Science · doi:10.1242/jcs.092262 · Cited by 149
Liu, R., Fu, A., Hoffman, A. E., Zheng, T., & Zhu, Y. (2013) · BMC Cell Biology · doi:10.1186/1471-2121-14-1 · Cited by 147
Garaude, J., Kent, A., van Rooijen, N., & Blander, J. M. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3002868 · Cited by 147
Leelahavanichkul, K., Amornphimoltham, P., Molinolo, A., Basile, J. R., Koontongkaew, S., & Gutkind, J. S. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.10.003 · Cited by 145
Kaempferol inhibits UVB-induced COX-2 expression by suppressing Src kinase activity
Lee, K., Lee, K. W., Jung, S. K., Lee, E. J., Heo, Y.-S., Bode, A. M., Lubet, R. A., Lee, H. J., & Dong, Z. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.042 · Cited by 144
Clinical patterns of metastasis
Leong, S. P. L., Cady, B., Jablons, D. M., García‐Aguilar, J., Reintgen, D. S., Jakub, J. W., Pendas, S., Duhaime, L. A., Cassell, R. T., Gardner, M. S., et al. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-8502-8 · Cited by 144
Tyagi, A. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh180 · Cited by 144
Anti-VEGF– and anti-VEGF receptor–induced vascular alteration in mouse healthy tissues
Yang, Y., Zhang, Y., Cao, Z., Ji, H. L., Yang, X., Iwamoto, H., Wahlberg, E., Länne, T., Sun, B., & Cao, Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301331110 · Cited by 143
Self-citationKhan, N., Adhami, V. M., & Mukhtar, H. (2009) · Nutrition and Cancer · doi:10.1080/01635580903285056 · Cited by 143
Yoysungnoen, B., Wirachwong, P., Bhattarakosol, P., Niimi, H., & Patumraj, S. (2006) · PubMed · Cited by 142
Yang, Q., Wang, B., Zang, W., Wang, X., Liu, Z., Li, W., & Jia, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070627 · Cited by 142
Wang, C., Wen, M., Wang, H., Hsieh, C., Li, Y., Liu, P., Lin, F., & Liao, J. K. (2008) · Circulation · doi:10.1161/circulationaha.108.790469 · Cited by 142
Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis
Ferrara, N. (2010) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283386660 · Cited by 141
Huang, C., Tsai, S., Wang, Y., Pan, M., Kao, J., & Way, T. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800592 · Cited by 139
Singh, R. P., Dhanalakshmi, S., Agarwal, C., & Agarwal, R. (2004) · Oncogene · doi:10.1038/sj.onc.1208276 · Cited by 139
Kaempferol induced the apoptosis via cell cycle arrest in human breast cancer MDA-MB-453 cells
Choi, E. J., & Ahn, W. S. (2008) · Nutrition Research and Practice · doi:10.4162/nrp.2008.2.4.322 · Cited by 138
Kwon, G. T., Cho, H., Chung, W., Park, K.-K., Moon, A., & Park, J. H. Y. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2008.06.005 · Cited by 135
Antioxidant Induces DNA Damage, Cell Death and Mutagenicity in Human Lung and Skin Normal Cells
Lu, L. Y., Ou, N., & Lu, Q. (2013) · Scientific Reports · doi:10.1038/srep03169 · Cited by 134
Saldanha, S. N., Kala, R., & Tollefsbol, T. O. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.01.024 · Cited by 133
Deng, B., Zhu, J., Wang, Y., Liu, T., Ding, Y., Xiao, W., Lu, G., Bo, P., & Shen, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063777 · Cited by 132
Zhou, J., Yu, L., Zhong, Y., & Blackburn, G. L. (2003) · Journal of Nutrition · doi:10.1093/jn/133.2.516 · Cited by 131
Cancer Inhibition through Circadian Reprogramming of Tumor Transcriptome with Meal Timing
Li, X., Delaunay, F., Dulong, S., Claustrat, B., Zampera, S., Fujii, Y., Teboul, M., Beau, J., & Lévi, F. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4235 · Cited by 131
Matsuda, H., Li, Y., MURAKAMI, T., Ninomiya, K., Yamahara, J., & YOSHIKAWA, M. (1997) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.20.1092 · Cited by 129
Chen, H., Lin, C.-M., Lee, C., Shih, N.-C., Peng, S., Tsuzuki, M., Amagaya, S., Huang, W., & Yang, J. (2013) · Oncology Reports · doi:10.3892/or.2013.2490 · Cited by 129
Jiang, C., Agarwal, R., & Lü, J. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3474 · Cited by 128
Gershon, T. R., Crowther, A., Tikunov, A. P., García, I., Annis, R. P., Yuan, H., Miller, C. R., Macdonald, J. M., Olson, J. M., & Deshmukh, M. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-2 · Cited by 128
Induction of ID2 Expression by Hypoxia-inducible Factor-1
Löfstedt, T., Jögi, A., Sigvardsson, M., Gradin, K., Poellinger, L., Påhlman, S., & Axelson, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402904200 · Cited by 127
Singh, R. P., Sharma, G. D., Dhanalakshmi, S., Agarwal, C., & Agarwal, R. (2003) · PubMed · Cited by 127
Increased Superoxide and Endothelial NO Synthase Uncoupling in Blood Vessels of Bmal1-Knockout Mice
Anea, C. B., Cheng, B., Sharma, S., Kumar, S., Caldwell, R. W., Yao, L., Ali, M. I., Merloiu, A. M., Stepp, D. W., Black, S. M., et al. (2012) · Circulation Research · doi:10.1161/circresaha.111.261750 · Cited by 127
Intussusceptive microvascular growth in tumors
Ribatti, D., & Djonov, V. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.10.040 · Cited by 124
Self-citationJensen, L. D., Cao, Z., Nakamura, M., Yang, Y., Bräutigam, L., Andersson, P., Zhang, Y., Wahlberg, E., Länne, T., Hosaka, K., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.07.005 · Cited by 124
Self-citationXu, P., Yin, Q., Shen, J., Chen, L., Yu, H., Zhang, Z., & Li, Y. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.06.053 · Cited by 124
Hosaka, K., Yang, Y., Seki, T., Nakamura, M., Andersson, P., Rouhi, P., Yang, X., Jensen, L. D., Lim, S., Feng, N., et al. (2013) · Nature Communications · doi:10.1038/ncomms3129 · Cited by 124
Self-citationTrapp, V., Parmakhtiar, B., Papazian, V., Willmott, L. J., & Fruehauf, J. P. (2010) · Angiogenesis · doi:10.1007/s10456-010-9187-8 · Cited by 123
Regulation of apoptosis by the circadian clock through NF-κB signaling
Lee, J. H., & Sancar, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108125108 · Cited by 122
Huang, Y., Zhou, Y., Fan, Y., & Zhou, D. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.01.043 · Cited by 122
Curcumin Suppresses Proliferation of Colon Cancer Cells by Targeting CDK2
Lim, T., Lee, S., Huang, Z., Lim, D. Y., Chen, H., Jung, S. K., Bode, A. M., Lee, K. W., & Dong, Z. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0387 · Cited by 122
Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer
Oshima (2011) · Oncology Reports · doi:10.3892/or.2011.1207 · Cited by 121
Gomez, L. S., Zancan, P., Marcondes, M. C., Ramos-Santos, L., Meyer‐Fernandes, J. R., Sola‐Penna, M., & Silva, D. (2013) · Biochimie · doi:10.1016/j.biochi.2013.02.013 · Cited by 120
Tyagi, A., Singh, R. P., Ramasamy, K., Raina, K., Redente, E. F., Dwyer‐Nield, L. D., Radcliffe, R. A., Malkinson, A. M., & Agarwal, R. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0095 · Cited by 120
From tumor cell metabolism to tumor immune escape
Villalba, M., Rathore, M. G., López-Royuela, N., Krzywińska, E., Garaude, J., & Allende-Vega, N. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.04.024 · Cited by 119
Curcumin inhibits COPD-like airway inflammation and lung cancer progression in mice
Moghaddam, S. J., Barta, P., Mirabolfathinejad, S. G., Ammar-Aouchiche, Z., Garza, N., Vo, T. T., Newman, R. A., Aggarwal, B. B., Evans, C. M., Tuvim, M. J., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp229 · Cited by 117
Parikh, N. R., Mandal, A., Bhatia, D., Siveen, K. S., Sethi, G., & Bishayee, A. (2014) · Phytochemistry Reviews · doi:10.1007/s11101-014-9337-5 · Cited by 117
Xiang, L., Gilkes, D. M., Chaturvedi, P., Luo, W., Hu, H., Takano, N., Liang, H., & Semenza, G. L. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1102-5 · Cited by 114
Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro
Lanzilli, G., Fuggetta, M. P., Tricarico, M., Cottarelli, A., Serafino, A., Falchetti, R., Ravagnan, G., Turriziani, M., Adamo, R., Franzese, O., et al. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.3.641 · Cited by 114
Chirasani, S. R., Leukel, P., Gottfried, E., Hochrein, J., Stadler, K., Neumann, B. H., Oefner, P. J., Gronwald, W., Bogdahn, U., Hau, P., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27712 · Cited by 114
Lunt, S. J., Kalliomäki, T., Brown, A., Yang, V. X. D., Milosevic, M., & Hill, R. P. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-2 · Cited by 111
Zhou, J., Yu, L., Mai, Z., & Blackburn, G. L. (2003) · International Journal of Cancer · doi:10.1002/ijc.11549 · Cited by 109
Macpherson, H., Pipingas, A., & Pase, M. P. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.049304 · Cited by 107
Kaempferol nanoparticles achieve strong and selective inhibition of ovarian cancer cell viability
Li, B., Luo, Jiang, B., Li, Jiang, & Chen, Y. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s33670 · Cited by 107
Self-citationLin, H., Yan, J., Wang, Z., Hua, F., Yu, J., Sun, W., Li, K., Liu, H., Yang, H., Lv, Q., et al. (2012) · Hepatology · doi:10.1002/hep.25991 · Cited by 106
Self-citationMelatonin and Associated Signaling Pathways that Control Normal Breast Epithelium and Breast Cancer
Hill, S. M., Blask, D. E., Xiang, S., Yuan, L., Mao, L., Dauchy, R. T., Dauchy, E. M., Frasch, T., & Duplessis, T. (2011) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-011-9222-4 · Cited by 106
Hofmann, M., Guschel, M., Bernd, A., Bereiter-Hahn, J., Kaufmann, R., Tandi, C., Wiig, H., & Kippenberger, S. (2006) · Neoplasia · doi:10.1593/neo.05469 · Cited by 106
Rofstad, E. K., Tunheim, S. H., Mathiesen, B. S., Graff, B. A., Halsør, E. F., Nilsen, K., & Galappathi, K. (2002) · PubMed · Cited by 106
Hypoxia enhances LPA-induced HIF-1α and VEGF expression: Their inhibition by resveratrol
Park, S. Y., Jeong, K. J., Lee, J., Yoon, D. S., Choi, W. S., Kim, Y. K., Han, J. W., Kim, Y. M., Kim, B. K., & Lee, H. Y. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.08.011 · Cited by 105
Szic, K. S. V., de Beeck, K. O., Ratman, D., Wouters, A., Beck, I. M. E., Declerck, K., Heyninck, K., Fransén, E., Bracke, M., Bosscher, K. D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087850 · Cited by 104
Wang, L., Li, H.-T., Wang, S., Liu, R., Wu, Z., Wang, C., Wang, Y., & Chen, M. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0112-0 · Cited by 104
Sen, T., Moulik, S., Dutta, A., Choudhury, P. R., Banerji, A., Das, S., Roy, M., & Chatterjee, A. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.11.018 · Cited by 104
Epigallocatechin-3-Gallate Inhibits Stem-Like Inflammatory Breast Cancer Cells
Mineva, N. D., Paulson, K. E., Naber, S. P., Yee, A. S., & Sonenshein, G. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073464 · Cited by 103
Dietary Lutein from Marigold Extract Inhibits Mammary Tumor Development in BALB/c Mice
Park, J. S., Chew, B. P., & Wong, T. S. (1998) · Journal of Nutrition · doi:10.1093/jn/128.10.1650 · Cited by 103
Roy, R. V., Suman, S., Das, T. P., Luevano, J. E., & Damodaran, C. (2013) · Journal of Natural Products · doi:10.1021/np400441f · Cited by 101
Wang, Y., Dong, Y., Wang, W.-M., Xie, X., Wang, Z., Chen, R., Chen, J., Gao, D., Cui, J., & Ren, Z. (2013) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-32-51 · Cited by 100
Self-citationMoreira, L., Araújo, I., Costa, T., Correia‐Branco, A., Faria, A., Martel, F., & Keating, E. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.05.001 · Cited by 99
Anticancer effects of (−)-epigallocatechin-3-gallate on ovarian carcinoma cell lines
Huh, S. W., Bae, S. M., Kim, Y., Lee, J. M., Namkoong, S. E., Lee, I. P., Kim, S. H., Kim, C. K., & Ahn, W. S. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.05.031 · Cited by 99
Vaughan, R. A., Garcia‐Smith, R., Dorsey, J., Griffith, J. K., Bisoffi, M., & Trujillo, K. A. (2013) · International Journal of Cancer · doi:10.1002/ijc.28264 · Cited by 99
Xu, W., Liu, J., Li, C., Wu, H., & Yan-wen, L. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.01.044 · Cited by 99
Tumor Lymphangiogenesis as a Potential Therapeutic Target
Duong, T., Koopman, P. A., & François, M. (2012) · Journal of Oncology · doi:10.1155/2012/204946 · Cited by 98
Thomas, P., Wang, Y., Zhong, J., Kosaraju, S. L., O’Callaghan, N. J., Zhou, X., & Fenech, M. F. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.10.016 · Cited by 98
Kim, A. L., Zhu, Y., Zhu, H., Han, L., Kopelovich, L., Bickers, D. R., & Athar, M. (2006) · Experimental Dermatology · doi:10.1111/j.1600-0625.2006.00445.x · Cited by 98
Peppicelli, S., Bianchini, F., Torre, E., & Calorini, L. (2014) · Clinical & Experimental Metastasis · doi:10.1007/s10585-014-9637-6 · Cited by 97
Inhibition of casein kinase 1-epsilon induces cancer-cell-selective, PERIOD2-dependent growth arrest
Yang, W. S., & Stockwell, B. R. (2008) · Genome biology · doi:10.1186/gb-2008-9-6-r92 · Cited by 97
Inflammation Induced by MMP-9 Enhances Tumor Regression of Experimental Breast Cancer
Leifler, K. S., Svensson, S., Abrahamsson, A. E., Bendrik, C., Robertson, J. V., Gauldie, J., Olsson, A., & Dabrosin, C. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202610 · Cited by 97
Self-citationAnderson, C. J., Hoare, S. F., Ashcroft, M. A., Bilsland, A. E., & Keith, W. N. (2005) · Oncogene · doi:10.1038/sj.onc.1209011 · Cited by 96
Self-citationInducing apoptosis of cancer cells using small-molecule plant compounds that bind to GRP78
Martin, S., Lamb, H. K., Brady, C., Lefkove, B., Bonner, M. Y., Thompson, P., Lovat, P. E., Arbiser, J. L., Hawkins, A. R., & Redfern, C. P. F. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.325 · Cited by 96
Filomeni, G., Graziani, I., Rotilio, G., & Ciriolo, M. R. (2007) · Genes & Nutrition · doi:10.1007/s12263-007-0059-9 · Cited by 94
Self-citationHahm, E., Lee, J., Kim, S., Sehrawat, A., Arlotti, J. A., Shiva, S. S., Bhargava, R., & Singh, S. V. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt153 · Cited by 93
Cancer-linked targets modulated by curcumin.
Hasima, N., & Aggarwal, B. B. (2012) · PubMed · Cited by 92
Grogan, P. T., Sleder, K. D., Samadi, A. K., Zhang, H., Timmermann, B. N., & Cohen, M. S. (2012) · Investigational New Drugs · doi:10.1007/s10637-012-9888-5 · Cited by 92
Mao, L., Dauchy, R. T., Blask, D. E., Slakey, L. M., Xiang, S., Yuan, L., Dauchy, E. M., Shan, B., Brainard, G. C., Hanifin, J. P., et al. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1071 · Cited by 91
Resveratrol inhibits proliferation, angiogenesis and induces apoptosis in colon cancer cells
Fouad, M. A., Agha, A., Merzabani, M. A., & Shouman, S. A. (2013) · Human & Experimental Toxicology · doi:10.1177/0960327113475679 · Cited by 91
Xu, Y., Zhang, J., Han, J., et al. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.03.005 · Cited by 87
Kaur, M., Balaiya, V., Tyagi, A., Deep, G., Katiyar, S., Agarwal, C., & Agarwal, R. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0304 · Cited by 87
van Meeteren, M. E., Hendriks, J. J. A., Dijkstra, C. D., & van Tol, E. A. F. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.10.018 · Cited by 86
Wang, B., Sun, J., Li, X., Zhou, Q., Bai, J., Shi, Y., & Le, G. (2013) · Nutrition Research · doi:10.1016/j.nutres.2013.07.016 · Cited by 84
Srivastava, R. K., Unterman, T. G., & Shankar, S. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0300-5 · Cited by 84
Curcumin and Silibinin Inhibit Telomerase Expression in T47D Human Breast Cancer Cells
Nasiri, M., Zarghami, N., Nejati‐Koshki, K., Mollazadeh, M., Pourhassan‐Moghaddam, M., Yamchi, M. R., Jahanban‐Esfahlan, R., Barkhordari, A., & Alibakhshi, A. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.6.3449 · Cited by 84
Adhami, V. M., Afaq, F., & Ahmad, N. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5819 · Cited by 83
Lindahl, G., Saarinen, N., Abrahamsson, A. E., & Dabrosin, C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2289 · Cited by 83
Self-citationKaempferol Inhibits IL-4-Induced STAT6 Activation by Specifically Targeting JAK3
Cortés, J. R., Perez-G, M., Rivas, M. D., & Zamorano, J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3881 · Cited by 82
Islam, N., Haqqi, T. M., Jepsen, K. J., et al. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10317 · Cited by 80
Gene Transfer of Matrix Metalloproteinase-9 Induces Tumor Regression of Breast CancerIn vivo
Bendrik, C., Robertson, J. V., Gauldie, J., & Dabrosin, C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0295 · Cited by 80
Self-citationFilomeni, G., Desideri, E., Cardaci, S., Graziani, I., Piccirillo, S., Rotilio, G., & Ciriolo, M. R. (2010) · Autophagy · doi:10.4161/auto.6.2.10971 · Cited by 79
Self-citationDayan, D., Salo, T. A., Salo, S., Nyberg, P., Nurmenniemi, S., Costea, D. E., & Vered, M. (2012) · Cancer Medicine · doi:10.1002/cam4.24 · Cited by 78
Antiangiogenic effect of licochalcone A
Kim, Y. H., Shin, E. K., Kim, D. H., Lee, H. H., Park, J. H. Y., & Kim, J. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.006 · Cited by 78
Liu, J., Wu, N., Ma, L., Liu, M., Liu, G., Zhang, Y., & Lin, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091606 · Cited by 77
Antiangiogenic effects of melatonin in endothelial cell cultures
Garcia, V. A., González, A., Alonso‐González, C., Martínez‐Campa, C., & Cos, S. (2013) · Microvascular Research · doi:10.1016/j.mvr.2013.02.008 · Cited by 77
Sánchez‐Sánchez, A. M., Martín, V., García‐Santos, G., Rodríguez‐Blanco, J., Zapico, S. C., Garnacho, S. S., Antolín, I., & Rodríguez, C. (2011) · Free Radical Research · doi:10.3109/10715762.2011.623700 · Cited by 77
Campbell, N., Greenaway, J. B., Henkin, J., Moorehead, R. A., & Petrik, J. (2010) · Neoplasia · doi:10.1593/neo.91880 · Cited by 76
Kang, N., Wang, M., Wang, Y., Zhang, Z.-N., Cao, H.-R., Lv, Y., Yang, Y., Fan, P.-H., Qiu, F., & Gao, X. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.02.024 · Cited by 76
Meeran, S. M., Mantena, S. K., & Katiyar, S. K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2672 · Cited by 76
Raina, K., Agarwal, C., Wadhwa, R., Serkova, N. J., & Agarwal, R. (2013) · Autophagy · doi:10.4161/auto.23960 · Cited by 75
Co‐ordinated autophagy with resveratrol and γ‐tocotrienol confers synergetic cardioprotection
Lekli, I., Ray, D., Mukherjee, S., Gurusamy, N., Ahsan, M. K., Juhász, B., Bak, I., Tósaki, Á., Gherghiceanu, M., Popescu, L. M., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00921.x · Cited by 74
Metabolic regulation and redox activity as mechanisms for angioprevention by dietary phytochemicals
Tosetti, F., Noonan, D. M., & Albini, A. (2009) · International Journal of Cancer · doi:10.1002/ijc.24677 · Cited by 73
The circadian clock gene BMAL1 is a novel therapeutic target for malignant pleural mesothelioma
Elshazley, M., Sato, M., Hase, T., Yamashita, R., Yoshida, K., Toyokuni, S., Ishiguro, F., Osada, H., Sekido, Y., Yokoi, K., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27598 · Cited by 73
An association between clock genes and clock‐controlled cell cycle genes in murine colorectal tumors
Soták, M., Polidarová, L., Ergang, P., Sumová, A., & Pácha, J. (2012) · International Journal of Cancer · doi:10.1002/ijc.27760 · Cited by 72
Rana, S., Munawar, M. A., Shahid, A., Malik, M., Ullah, H., Fatima, W., Mohsin, S., & Mahmood, S. (2013) · Molecular Biology Reports · doi:10.1007/s11033-013-2841-7 · Cited by 72
Slivova, V., Zaloga, G. P., DeMichele, S. J., Mukerji, P., Huang, Y. S., Siddiqui, R. A., Harvey, K. A., Valachovicova, T., & Slíva, D. (2005) · Nutrition and Cancer · doi:10.1207/s15327914nc5201_9 · Cited by 72
Schrohl, A., Christensen, I. J., Pedersen, A. N., Jensen, V., Mouridsen, H. T., Murphy, G., Foekens, J. A., Bruünner, N., & Holten-Andersen, M. (2003) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300019-mcp200 · Cited by 72
Wu, J., Dauchy, R. T., Tirrell, P. C., Wu, S. S., Lynch, D. T., Jitawatanarat, P., Burrington, C. M., Dauchy, E. M., Blask, D. E., & Greene, M. W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3837 · Cited by 71
Thelen, P., Wuttke, W., Jarry, H., Grzmil, M., & Ringert, R. H. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000121329.37206.1b · Cited by 70
Resveratrol‐induced apoptosis is enhanced in low pH environments associated with cancer
Shamim, U., Hanif, S., Albanyan, A., Beck, F. W. J., Bao, B., Wang, Z. P., Banerjee, S., Sarkar, F. H., Mohammad, R. M., Hadi, S. M., et al. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22865 · Cited by 70
Self-citationTsai, S.-H., Liang, Y., Lin‐Shiau, S., & Lin, J.-K. (1999) · Journal of Cellular Biochemistry · Cited by 70
Sharma, C., Nusri, Q. E.-A., Begum, S., Javed, E., Rizvi, T. A., & Hussain, A. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.9.4815 · Cited by 70
Anti-angiogenesis and angioprevention: mechanisms, problems and perspectives
Bisacchi, D., Benelli, R., Vanzetto, C., Ferrari, N., Tosetti, F., & Albini, A. (2003) · Cancer Detection and Prevention · doi:10.1016/s0361-090x(03)00030-8 · Cited by 69
Sinha, P., & Ostrand‐Rosenberg, S. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1470-2 · Cited by 69
Hahm, E., Lee, J., & Singh, S. V. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22050 · Cited by 68
Kiéda, C., Hafny‐Rahbi, B. E., Collet, G., Lamerant‐Fayel, N., Grillon, C., Guichard, A., Dulak, J., Józkowicz, A., Kotlinowski, J., Fylaktakidou, K. C., et al. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-0992-6 · Cited by 68
Blockage of melatonin receptors impairs p53-mediated prevention of DNA damage accumulation
Santoro, R., Mori, F., Marani, M., Grasso, G., Cambria, M. A., Blandino, G., Muti, P. C., & Strano, S. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt025 · Cited by 68
Forghani, P., Khorramizadeh, M. R., & Waller, E. K. (2014) · Cancer Medicine · doi:10.1002/cam4.186 · Cited by 66
Tyagi, A., Agarwal, C., & Agarwal, R. (2002) · PubMed · Cited by 66
Reappraising antiangiogenic therapy for breast cancer
Kerbel, R. S. (2011) · The Breast · doi:10.1016/s0960-9776(11)70295-8 · Cited by 65
Circadian Regulation of mTOR by the Ubiquitin Pathway in Renal Cell Carcinoma
Okazaki, H., Matsunaga, N., Fujioka, T., Okazaki, F., Akagawa, Y., Tsurudome, Y., Ono, M., Kuwano, M., Koyanagi, S., & Ohdo, S. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3241 · Cited by 65
Vascular endothelial growth factor-induced chemotaxis and IL-10 from T cells
Shin, J.-Y., Yoon, I., Kim, J.-S., Kim, B., & Park, C. (2009) · Cellular Immunology · doi:10.1016/j.cellimm.2009.01.006 · Cited by 65
Jeong, S. K., Yang, K., Park, Y. S., Choi, Y. J., Oh, S. J., Lee, C. W., Lee, K. Y., Jeong, M. H., & Jo, W. S. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.07.004 · Cited by 64
Shen, X., Zhang, Y., Feng, Y., Zhang, L., Li, J., Xie, Y., & Luo, X. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2251 · Cited by 64
Lee, W., Chen, Y., Shih, C.-M., Lin, C., Cheng, C., Chen, K., & Lin, C.-W. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.10.027 · Cited by 64
Self-citationBaño‐Otálora, B., Madrid, J. A., Álvarez‐Sánchez, N., Vicente, V., & Rol, M. A. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00531.x · Cited by 64
Tumor growth suppression in vivo by overexpression of the circadian component, PER2
Miyazaki, K., Wakabayashi, M., Hara, Y., & Ishida, N. (2010) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01384.x · Cited by 64
Singh, B. N., Singh, A. K., Singh, A., Naqvi, A. H., & Singh, B. R. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9457-1 · Cited by 63
Ahmad, N., Adhami, V. M., Gupta, S., Cheng, P., & Mukhtar, H. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2704 · Cited by 63
Antitumor activities of synthetic and natural stilbenes through antiangiogenic action
Kimura, Y., Sumiyoshi, M., & Baba, K. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00948.x · Cited by 63
Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts
Bussink, J., Kaanders, J. H. A. M., Rijken, P. F. J. W., Martindale, C. A., & van der Kogel, A. J. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.9 · Cited by 63
Golding, J. P., Wardhaugh, T., Patrick, L., Turner, M., Phillips, J. B., Bruce, J. I., & Kimani, S. G. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.391 · Cited by 63
Song, W., Dang, Q., Xu, D., Chen, Y., Zhu, G., Wu, K., Zeng, J., Long, Q., Wang, X., He, D., et al. (2014) · Oncology Reports · doi:10.3892/or.2014.2965 · Cited by 63
Self-citationBandyopadhyay, S., Romero, J. R., & Chattopadhyay, N. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.01.015 · Cited by 61
Hypoxia-inducible factors as key regulators of tumor inflammation
Mamlouk, S., & Wielockx, B. (2013) · International Journal of Cancer · doi:10.1002/ijc.27901 · Cited by 61
Wang, X., Hao, M.-W., Dong, K., Fang, L., Ren, J.-H., & Zhang, H. (2009) · Archives of Pharmacal Research · doi:10.1007/s12272-009-1912-8 · Cited by 61
Valenti, D., Lidia de, B. A. R. I., Manente, G. A., Rossi, L., Mutti, L., Moro, L., & Vacca, R. A. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.07.014 · Cited by 61
Martínez‐Campa, C., Alonso‐González, C., Mediavilla, M. D., Cos, S., González, A., & Sánchez‐Barceló, E. J. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.001 · Cited by 61
Yeh, C., Hsieh, M., Lin, C., Chiou, H., Lin, P.-Y., Chen, T., & Yang, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056661 · Cited by 61
A Comprehensive Overview of Targeted Therapy in Metastatic Renal Cell Carcinoma
Mihály, Z., Sztupinszki, Z. M., Surowiak, P., & Győrffy, B. (2012) · Current Cancer Drug Targets · doi:10.2174/156800912802429265 · Cited by 60
Wu (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.600 · Cited by 59
Zhang, D., Hedlund, E., Lim, S., Chen, F., Zhang, Y., Sun, B., & Cao, Y. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016220108 · Cited by 59
Anti-angiogenic Activity of a Novel Class of Chemopreventive Compounds: Oleanic Acid Terpenoids
Sogno, I., Vannini, N., Lorusso, G., Cammarota, R., Noonan, D. M., Generoso, L., Sporn, M. B., & Albini, A. (2008) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-69297-3_19 · Cited by 58
Celastrol causes apoptosis and cell cycle arrest in rat glioma cells
Ge, P., Ji, X., Ding, Y., Wang, X., Fu, S., Meng, F., Jin, X., Ling, F., & Luo, Y. (2009) · Neurological Research · doi:10.1179/016164109x12518779082273 · Cited by 58
Tumor interstitial fluid as modulator of cancer inflammation, thrombosis, immunity and angiogenesis.
Baronzio, G., Schwartz, L. H., Kiselevsky, M. V., Guais, A., Sanders, E., Milanesi, G., Baronzio, M., & Freitas, I. (2012) · PubMed · Cited by 58
Corsini, E., Dell’Agli, M., Facchi, A., Fabiani, E. D., Lucchi, L., Boraso, M., Marinovich, M., & Galli, C. L. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf100471n · Cited by 57
Salado, C., Olaso, E., Gallot, N., Valcárcel, M., Egilegor, E., Mendoza, L., & Vidal‐Vanaclocha, F. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-59 · Cited by 57
Deep, G., Gangar, S. C., Rajamanickam, S., Raina, K., Gu, M., Agarwal, C., Oberlies, N. H., & Agarwal, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034630 · Cited by 56
Effect of circadian clock mutations on DNA damage response in mammalian cells
Gaddameedhi, S., Reardon, J. T., Ye, R., Öztürk, N., & Sancar, A. (2012) · Cell Cycle · doi:10.4161/cc.21771 · Cited by 56
Jensen, L. D., & Cao, Y. (2013) · Cell Cycle · doi:10.4161/cc.23596 · Cited by 56
Self-citationNilsson, U. W., & Dabrosin, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4012 · Cited by 56
Self-citationPolymeric Tubulysin-Peptide Nanoparticles with Potent Antitumor Activity
Schluep, T., Gunawan, P., Ma, L., Jensen, G. S., Duringer, J., Hinton, S., Richter, W., & Hwang, J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1848 · Cited by 55
Zaki‐Dizaji, M., Malehmir, M., Ghavamzadeh, A., Alimoghaddam, K., & Ghaffari, S. H. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0620-1 · Cited by 54
Kimura, Y., & Sumiyoshi, M. (2012) · Phytomedicine · doi:10.1016/j.phymed.2012.10.016 · Cited by 54
Chen, Z. (2012) · Oncology Reports · doi:10.3892/or.2012.1688 · Cited by 53
Role of ephrinB2 in nonproductive angiogenesis induced by Delta-like 4 blockade
Yamanda, S., Ebihara, S., Asada, M., Okazaki, T., Niu, K., Ebihara, T., Koyanagi, A., Yamaguchi, N., Yagita∥, H., & Arai, H. (2009) · Blood · doi:10.1182/blood-2008-07-170381 · Cited by 52
Inhibition of fatty acid amide hydrolase by kaempferol and related naturally occurring flavonoids
Thors, L., Belghiti, M., & Fowler, C. J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.237 · Cited by 51
Hsiao, Y., Li, C., Chi, J.-Y., Tseng, J. T.-C., Chang, Y., Hsu, L., Lee, C.-H., Chang, T.-H., Wang, S., Wang, D. D. H., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2003648 · Cited by 51
Schäfer, H., Struck, B., Feldmann, E.-M., Bergmann, F., Grage‐Griebenow, E., Geismann, C., Ehlers, S., Altevogt, P., & Sebens, S. (2012) · Oncogene · doi:10.1038/onc.2012.44 · Cited by 51
Preise, D., Scherz, A. J., & Salomon, Y. (2011) · Photochemical & Photobiological Sciences · doi:10.1039/c0pp00315h · Cited by 50
Deeb, D., Gao, X., Liu, Y., Varma, N. R. S., Arbab, A. S., & Gautam, S. C. (2013) · Molecules · doi:10.3390/molecules18033250 · Cited by 50
Regulation of O2 consumption by the PI3K and mTOR pathways contributes to tumor hypoxia
Kelly, M., Hussien, K., Fokas, E., Kannan, P., Shipley, R. J., Ashton, T. M., Stratford, M. R. L., Pearson, N. C., & Muschel, R. J. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.02.007 · Cited by 49
Lipton, A., Ali, S. M., Leitzel, K. E., Demers, L. M., Evans, D. B., HAMER, P. J., Brown-Shimer, S. L., Pierce, K., & Carney, W. P. (2007) · Cancer · doi:10.1002/cncr.22637 · Cited by 49
Heeg, S., Hirt, N., Queisser, A., Schmieg, H., Thaler, M., Kunert, H., Quante, M., Goessel, G., von Werder, A., Harder, J., et al. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01796.x · Cited by 49
Matsubara, T., DiResta, G. R., Kakunaga, S., Li, D., & Healey, J. H. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00199 · Cited by 49
Denissova, N. G., Nasello, C., Yeung, P. L., Tischfield, J. A., & Brenneman, M. A. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr236 · Cited by 48
Growth Hormone Promotes Lymphangiogenesis
Bänziger-Tobler, N. E., Halin, C., Kajiya, K., & Detmar, M. J. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080060 · Cited by 47
Rath, S., Liebl, J., Fürst, R., Ullrich, A., Burkhart, J. L., Kazmaier, U., Herrmann, J. E., Müller, R., Günther, M., Schreiner, L., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02037.x · Cited by 46
Zgheib, A., Lamy, S., & Annabi, B. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.456533 · Cited by 46
Roy, S., Deep, G., Agarwal, C., & Agarwal, R. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr299 · Cited by 45
Vangestel, C., de Wiele, C. V., Damme, N. V., Staelens, S. G., Pauwels, P., Reutelingsperger, C. P. M., & Peeters, M. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.092650 · Cited by 45
Voss, M. J., Niggemann, B., Zänker, K. S., & Entschladen, F. (2010) · Current Molecular Medicine · doi:10.2174/156652410791317020 · Cited by 45
Li, H., Adachi, Y., Yamamoto, H., Min, Y., Ohashi, H., Ii, M., Arimura, Y., Endo, T., Lee, C., Carbone, D. P., et al. (2011) · Cancer · doi:10.1002/cncr.25893 · Cited by 44
An evaluation of the anti-tumor efficacy of oleanolic acid-loaded PEGylated liposomes
Tang, S., Gao, D., Zhao, T., Zhou, J., & Zhao, X. (2013) · Nanotechnology · doi:10.1088/0957-4484/24/23/235102 · Cited by 44
Ni, H., Zhao, W., Kong, X.-T., Li, H., & Ouyang, J. (2013) · Acta Haematologica · doi:10.1159/000354770 · Cited by 44
Melatonin Induces Apoptotic Cell Death via p53 in LNCaP Cells
Kim, C. H., & Yoo, Y. (2010) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2010.14.6.365 · Cited by 43
Dai, C., Sun, F., Zhu, C., & Hu, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063054 · Cited by 43
DLK1: A Novel Target for Immunotherapeutic Remodeling of the Tumor Blood Vasculature
Chi-Sabins, N., Taylor, J. L., Fabian, K. P., Appleman, L. J., Maranchie, J. K., Stolz, D. B., & Storkus, W. J. (2013) · Molecular Therapy · doi:10.1038/mt.2013.133 · Cited by 41
Hernández-Luna, M. A., Rocha‐Zavaleta, L., Vega, M. I., & Huerta‐Yépez, S. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.733874 · Cited by 41
CD200 Upregulation in Vascular Endothelium Surrounding Cutaneous Squamous Cell Carcinoma
Belkin, D. A., Mitsui, H., Wang, C. Q. F., Gonzalez, J., Zhang, S., Shah, K. R., Coats, I., Suárez‐Fariñas, M., Krueger, J. G., Felsen, D., et al. (2012) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.1609 · Cited by 40
YU, T., Liu, K., Wu, Y., Fan, J., Chen, J., Li, C., Zhu, G., Wang, Z., & Li, L. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1496 · Cited by 40
Self-citationPartridge, J. J., Madsen, M. A., Ardi, V. C., Papagiannakopoulos, T. Y., Kupriyanova, T. A., Quigley, J. P., & Deryugina, E. I. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705993200 · Cited by 39
Deeb, D., Gao, X., Liu, Y., Jiang, D., Divine, G., Arbab, A. S., Dulchavsky, S. A., & Gautam, S. C. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr030 · Cited by 38
Cited by
Zimna, A., & Kurpisz, M. (2015) · BioMed Research International · doi:10.1155/2015/549412 · Cited by 604
Tissue invasion and metastasis: Molecular, biological and clinical perspectives
Jiang, W. G., Sanders, A. J., Katoh, M., Ungefroren, H., Gieseler, F., Prince, M., Thompson, S. K., Zollo, M., Spano, D., Dhawan, P., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.008 · Cited by 515
Self-citationApplication of Radiosensitizers in Cancer Radiotherapy
Gong, L., Zhang, Y., Liu, C., Zhang, M., & Han, S. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s290438 · Cited by 479
Anlotinib inhibits angiogenesis via suppressing the activation of VEGFR2, PDGFRβ and FGFR1
Lin, B., Song, X., Yang, D., Bai, D., Yao, Y., & Lu, N. (2018) · Gene · doi:10.1016/j.gene.2018.02.026 · Cited by 384
Xie, C., Wan, X., Quan, H., Zheng, M., Fu, L., Li, Y., & Lou, L. (2018) · Cancer Science · doi:10.1111/cas.13536 · Cited by 348
Metadata
- Authors
- Wang, Z., Dabrosin, C., Yin, X., Fuster, M. M., Arreola, A., Rathmell, W. K., Generali, D., Nagaraju, G. P., El-Rayes, B., Ribatti, D., Chen, Y. C., Honoki, K., Fujii, H., Georgakilas, A. G., Nowsheen, S., Amedei, A., Niccolai, E., Amin, A., Ashraf, S. S., Helferich, B., Yang, X., Guha, G., Bhakta, D., Ciriolo, M. R., Aquilano, K., Chen, S., Halicka, D., Mohammed, S. I., Azmi, A. S., Bilsland, A., Keith, W. N., & Jensen, L. D.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 35
- Pages
- S224-S243
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2093412095
- Cited by
- 464
- References
- 426
- FWCI
- 22.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.